[ad#PhycoBiosciences AIM Interview]

Algae Medical Solutions – Part 5

Algae Diabetes Solutions

June 16, 2013

The Centers for Disease Control, (CDC) reported that one out of three American children born after the year 2000 will contract diabetes – predominantly due to a poor diet of nutrient-deficient calories. Over 40% of women are likely to contract diabetes. The plague of obesity and diabetes creates havoc on our educational system and creates immense drag on our health system.

The cost of diabetes in the U.S. approaches $200 billion annually. Neither the obesity nor the diabetes costs include the drag on education, social systems, businesses and the military. Our society will fail if we do not find solutions to obesity and diabetes quickly.

Childhood obesity causes diabetes when the body makes insufficient insulin or cannot use its own insulin effectively and sugars build up in the blood. Diabetes is one of the most common chronic diseases in children and adolescents and rates are escalating dramatically.

Diabetes is a serious disease because it is associated with an increased risk of life threatening complications such as a heart attack, stroke, or kidney disease. Overall, the risk for death among people with diabetes for these catastrophic complications is about four times that of people without diabetes. In addition to an earlier death, diabetes carries with it significant risks for serious complications such as blindness, the need for dialysis and limb amputation.

Diabetes and algae

Diabetes mellitus occurs when blood sugar levels become elevated. Type 1 diabetes is associated with the destruction of the cells in the pancreas that manufacture insulin. Individuals with Type 1 diabetes require lifelong insulin for the control of blood sugar levels. In Type 2 diabetes insulin levels are typically elevated, indicating a loss of sensitivity to insulin by the cells of the body.

Research on humans and animals shows algae components offer significant utility in the prevention and control of diabetes. Aligned studies have demonstrated algae’s therapeutic value for the diseases common with diabetics; cholesterol management, blood pressure, heart disease and cancers. Algae can moderate chronic inflammation that often precedes and accompany degenerative diseases. Algae compounds provide therapeutic value for diabetes and fat metabolism.

Kelp compounds moderate inflammatory diseases

Kelp compounds moderate inflammatory diseases

For example, kelp are brown seaweeds that contain up to 13 times more calcium than milk and powerful antioxidants that are not found in land plants: fucoxanthin and fucoidan. Kelps are macroalgae rich in B vitamins, vitamin C and vitamin K1 with high mineral content in magnesium, potassium and iron. The plentiful soluble dietary fibers in algae help avoid obesity and diabetes. The total fiber content of several algae species, (~6 g/100g), is greater than that of fruits and vegetables promoted for their fiber content: prunes (2.4 g), cabbage (2.9 g), apples (2.0 g) and brown rice (3.8 g).

The many varieties of kelp grow mostly in the oceans of the world. Kelp and other sea vegetables have been eaten by societies that lived near oceans and estuaries for centuries. Sea vegetables are commonly available in health food and Asian stores as dried sheets or cut pieces. Sea vegetables are commonly used as a nutritionally rich additive to salads, soups, stews and casseroles to add color, taste and texture.

The research reviewed here focuses on red and brown macroalgae but many of the same or similar compounds are abundant in other algae species.

Kelp, Nori and other Sea Vegetables

Kelp, Nori and other Sea Vegetables

Appetite control

Algae compounds provide a wide array of medical benefits for children plagued with obesity and diabetes. Two unique strategies may be called fill-gut and gut-full signals.

Fill-gut adds a small amount of dried algae eaten early in a normal meal, which then expands and fills the stomach. Alginates can absorb 300 times their weight in water, which fill the gut and suppresses appetite.

Fill-gut adds a small amount of dried algae eaten early in a normal meal, which then expands and fills the stomach. Alginates can absorb 300 times their weight in water, which fill the gut and suppresses appetite.

Certain algae-based compounds activate the stomach’s natural satiety signaling mechanism. The signal creates an artificial feeling of fullness, which signals the eater to stop eating. The signals also quash the nosh feeling.

Certain algae-based compounds activate the stomach’s natural satiety signaling mechanism. The signal creates an artificial feeling of fullness, which signals the eater to stop eating. The signals also quash the nosh feeling.

Algae strategies to prevent overeating

Studies show that sodium alginate reduces plasma glucose and protects the antioxidant system in diabetics. Alginic acid and other compounds in sea vegetables exert a protective effect against diabetes. Alginic acid may improve the sensitivity of cells to the action of insulin, thereby improving glucose tolerance and normalizing blood sugar.

Sodium alginate induces significantly lower postprandial rises in blood glucose, serum insulin and plasma C-peptides. The addition of sodium alginate in the diet leads to a delayed gastric emptying rate induced by the fiber, which moderates glucose response.

Algae polyphenol extracts have anti-diabetic effects through the modulation of glucose-induced oxidative stress. These extracts slow starch-digestive enzymes such as alpha-amylase and alpha-glucosidase.

Visible impacts

A 2012 lab rat study graphically describes the impacts of diabetes and hypoglycemic effect. Healthy rats at the same age and body weight reacted nimbly, and had hair that was bright and smooth. Alloxan was injected and the animals showed typical signs of diabetes mellitus: clumsiness, slow actions, dull colored fur and marasmus. Average body weights reduced significantly.

After kelp powder forage was administered, the action and hair color of animals in kelp treated and DM-model groups recovered gradually, with body weight becoming significantly higher than before treatment. Diabetic animals treated with a placebo continued to display signs of diabetes and to lose weight.

Insulin resistance syndrome

The cluster of medical conditions that make up the insulin resistance syndrome or metabolic syndrome significantly increases the risk of developing type-2 diabetes and atherosclerosis. Over one-third of adult Americans have insulin resistance or metabolic syndrome. Numerous studies show that diets high in sugar or high glycemic foods that the body transforms to sugar, create unhealthy loads of blood sugar and contribute to obesity and diabetes. A small dose of soluble alginate-fiber significantly reduces postprandial glycemia and gastric emptying in humans with diabetes. Both effects reduce prediabetic and diabetic symptoms.

People who consume alginate fibers in drinks, bars or in other forms experience a sensation of satiety, so they eat less and lose more weight. Human trials have shown significantly more weight loss when the diet includes alginates compared with the placebo group.

Hypoglycemic effects

Several lines of research have investigated algae’s ability to moderate hypoglycemic effects through enhancement of glucose uptake in the liver and in soleus muscles. Improved insulin sensitivity after algae treatment could be also due to lower serum non-esterified fatty acid levels. Insulin sensitivity tends to blunt elevated non-esterified fatty acids in people with diabetes.

Several algae species such as Ulva, Ascophyllum, Alaria, and Palmaria are rich in phenolic compounds that are natural antioxidants and exhibit bioactive properties. A phenolic rich extracts from various algae species have been shown to inhibit digestive enzymes and achieve anti-diabetic effects.

Algae pharmaceuticals and medicines are currently in trial phases. These valuable algae therapeutics should move through medical approval relatively quickly since they are natural products and, to date, have shown no allergic reactions.

More Like This…

HOME Algae Industry Jobs

Copyright ©2010-2013 AlgaeIndustryMagazine.com. All rights reserved. Permission granted to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
Joelle Kovach writes in the Peterborough Examiner that a company developing new technologies using the algae euglena to purify water has opened a new facility near Trent ...
Dr. Gloria Naa Dzama Addico and Kweku Amoako Atta deGraft-Johnson write in Graphic Online about the plight of the fisher folks in Ghana — in the throes of depleting fish ...
Michigan State University (MSU) and PHYCO2, an algae growth and CO2 sequestration company based in Santa Maria, CA, have entered into a partnership to develop algae techn...
Researchers at Michigan State University have built a molecular super protein tool that streamlines the molecular machinery of cyanobacteria making, they say, biofuels an...
Large prefabricated raceway ponds have been a missing element in algae cultivation scale-up. Now 22-m2 to 101-m2 Algae Raceway™ ponds featuring patent pending APIAC™ tech...
Modesto, California-based G3 Enterprises, Inc. has entered into an agreement with Commercial Algae Management (CAM) to represent their unique drying technology in the alg...
Tel Aviv, Israel-based UniVerve Ltd. has begun scaling-up its technological process for algae cultivation. The oil, which can be extracted with off-the-shelf wet extracti...
The Chesapeake Bay Seed Capital Fund, located in College Park, Maryland, has invested $150,000 into Manta Biofuel LLC, a company that produces crude oil from algae at a c...
The U.S. Department of Energy (DOE) has awarded Arizona State University (ASU) a three-year, $1 million grant to fund the Atmospheric Carbon Dioxide Capture and Membrane ...